The ICD-10 code for choledocholithiasis is K80.3. This code specifies the presence of gallstones in the common bile duct, used for diagnosis, treatment planning, and insurance billing.
Choledocholithiasis occurs when a gallstone migrates from the gallbladder into the common bile duct. The condition causes obstruction of bile flow, leading to jaundice, abdominal pain, fever, and potentially cholangitis. Accurate coding ensures proper clinical tracking and reimbursement.
The International Classification of Diseases, 10th Revision (ICD-10), is the global standard for classifying diseases and health conditions. Each code corresponds to a specific diagnosis. For choledocholithiasis, K80.3 is the precise code assigned when stones are confirmed in the common bile duct.
K80.3 falls under the category K80, which covers other specified diseases of the biliary tract. This subcategory includes various forms of biliary obstruction due to stones. The ".3" suffix specifically indicates choledocholithiasis, distinguishing it from gallstones in the gallbladder (K80.0) or other biliary complications.
Clinicians must confirm the location of the stone through imaging. Ultrasound typically detects gallbladder stones but may miss those in the common bile duct. Magnetic resonance cholangiopancreatography (MRCP) or endoscopic ultrasound (EUS) provides higher sensitivity for detecting choledocholithiasis. A confirmed diagnosis triggers the use of K80.3.
For example, a 62-year-old patient presents with right upper quadrant pain, elevated bilirubin, and a dilated common bile duct on ultrasound. MRCP confirms a 1.2 cm stone in the distal common bile duct. The physician performs an endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy and stone removal. The correct ICD-10 code for this scenario is K80.3.
Choledocholithiasis can be classified by severity and complications. The ICD-10 system uses additional codes to capture associated conditions:
| Code | Description | Use Case |
|---|---|---|
| K80.3 | Choledocholithiasis | Primary diagnosis when stones are in the common bile duct |
| K80.4 | Cholangitis due to choledocholithiasis | When infection develops from obstruction |
| K80.5 | Obstruction of the common bile duct due to calculus | Used when obstruction is documented but stone location is uncertain |
Using K80.3 alone is insufficient if complications arise. For instance, if the patient develops sepsis from infected bile, K80.4 takes precedence. The sequencing of codes matters: primary diagnosis first, then complications.
A common error is assigning K80.0 (gallstones in the gallbladder) instead of K80.3. This misclassification leads to inaccurate data reporting and potential claim denials. According to the Centers for Medicare & Medicaid Services (CMS), incorrect coding of biliary conditions results in 12% of denied claims in outpatient settings.
Choledocholithiasis is often mistaken for cholecystitis. Cholecystitis involves inflammation of the gallbladder, coded as K81.9. The two conditions can coexist, but they require separate codes. A patient with both gallbladder stones and a common bile duct stone needs both K80.0 and K80.3.
Another confusion arises with pancreatitis. Bile duct obstruction can trigger acute pancreatitis. If a patient presents with choledocholithiasis and elevated amylase/lipase, the coder must assign both K80.3 and K85.9 (acute pancreatitis, unspecified). Failure to do so underreports comorbidities and affects risk adjustment.
One non-obvious distinction: K80.3 applies only when the stone is confirmed in the common bile duct. If imaging shows a mass or stricture, but no stone is visualized, K80.3 should not be used. The correct code in that case may be K76.8 (other specified diseases of the liver and biliary tract).
In my work reviewing surgical records, I once encountered a case where a patient underwent ERCP for suspected choledocholithiasis. Pre-op imaging showed a dilated bile duct, but no stone was retrieved during the procedure. The initial chart listed K80.3. After review, we changed the code to K76.8 because no stone was confirmed. This corrected the diagnosis and prevented downstream billing issues.
Accurate coding supports public health surveillance. The World Health Organization (WHO) tracks biliary disease incidence using ICD-10 codes. Data from 2022 shows choledocholithiasis accounted for 1.8 million hospitalizations globally, with K80.3 being the most frequently reported code in this group.
For providers, understanding the nuances of K80.3 ensures compliance. The American Medical Association (AMA) emphasizes that coders must verify clinical documentation and use only codes supported by diagnostic evidence.
Correct use of the ICD-10 code for choledocholithiasis is essential for accurate patient care, research, and financial processing. Always validate the diagnosis with imaging and clinical findings before assigning K80.3.